An anticancer agent in development promotes regeneration of damaged heart muscle – an unexpected research finding that may help prevent congestive heart failure in the future.
A new Berkeley Lab-led study found that the sticky residue left behind by tobacco smoke led to changes in weight and blood cell count in mice. These latest findings add to a growing body of evidence that thirdhand smoke exposure may be harmful.
Researchers at University of California San Diego School of Medicine, Rady Children’s Hospital-San Diego and Betty Irene Moore School of Nursing at University of California Davis have received a $2 million grant from the Patient-Centered Outcomes Research Institute (PCORI) for a three-year study to look at the effectiveness of two treatment options for children with KD who are resistant to initial therapy.
Although blockages in the arteries of the heart, also known as coronary artery disease, are the best known, there are many other diseases that may involve the actual structures inside the heart.
University of Virginia Children's Hospital and Children's Hospital of The King's Daughters have appointed Dr. Jay Gangemi as surgical director of the new regional collaborative for cardiac care at Children’s Hospital of The King’s Daughters. The UVA/CHKD collaboration, which has been in development over the past year, combines the efforts of pediatric cardiologists, cardiac surgeons, cardiac anesthesiologists, intensive care physicians and cardiac support professionals from both institutions with the goal of improving outcomes for children with complex congenital heart defects.
The Peter Munk Cardiac Centre at Toronto General Hospital today announced the launch of the FIBrinogen REplenishment in Surgery (FIBRES) study in acquired fibrinogen deficiency.
Penn Medicine's heart failure team is using big data to kick-start a project that is working to improve communication across the continuum of care, and ultimately reduce readmissions for heart failure patients.
Pennsylvania Health Care Cost Containment Council report shows successful decline in hospital-based mortality and readmissions for CABG and valve surgery in Pennsylvania.
Every minute, a woman dies from heart disease in the United States – it is the number one killer of women, causing one in three deaths each year, according to the American Heart Association (AHA).
Unique research being done at OSU Wexner Medical Center is changing the way doctors treat one type of irregular heartbeat called atrial fibrillation. Scientists here are the only ones in the world studying revived human atria, donated after a heart transplant, and translating their findings to improve treatment.
A routine blood test that measures kidney function can be a valuable predictor of short-term outcomes for stroke patients, according to a study led by a neurologist at Wake Forest Baptist Medical Center.
UNC Medical Center is the first in the Mid Atlantic U.S. to treat patients with the EnSite Precision™ cardiac mapping system, a next-generation platform designed to provide automation, flexibility and accuracy for diagnostic mapping used in ablation procedures to treat patients with abnormal heart rhythms (cardiac arrhythmias). UNC Medical Center was among the first sites in the United States to utilize this technology, which recently received FDA clearance.
Baylor Heart and Vascular Services at Fort Worth on Tuesday, November 15, became the first program in Texas to implant the only FDA-approved device designed to prevent blood clots from entering the brain by sealing a hole in the heart. The device is designed to help reduce the risk of recurrent cryptogenic strokes in patients diagnosed with a patent foramen ovale (PFO) – a small opening between the upper chambers of the heart.
In patients with severe obstructive sleep apnea (OSA), oral appliances that treat the condition by moving the lower jaw forward appear to improve sleep but not reduce key risk factors for developing heart and other cardiovascular disease, according to new research published online, ahead of print in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
MedStar Heart & Vascular Institute has implanted to date more of the stroke-reducing WATCHMAN™ devices than any other institution in the Mid-Atlantic region. It has performed a total of 100 procedures to prevent stroke in patients with atrial fibrillation.
People who internalize weight bias, such as fat-shaming and discrimination, are more likely to have risk factors for heart disease and diabetes, according to a new study published in Obesity, the scientific journal of The Obesity Society (TOS). The stares and the sideways glances, the hurled insults and the unsolicited advice that people struggling with obesity endure daily add up to a pernicious culture of weight bias that many people internalize, which can be making them less healthy.
Cardiac muscle patches in this proof-of-concept research may represent an important step toward the clinical use of 3-D-printing technology, as researchers have grown heart tissue by seeding a mix of human cells onto a 1-micron-resolution scaffold made with a 3-D printer.
More than $9 million in federal grants will help fund researchers in the Ohio State University Davis Heart and Lung Research Institute (DHLRI) and their collaborators across the university campus to investigate new causes and treatments for cardiovascular disease.
Believe it or not, winter has officially begun! And, although there has been a lack of significant snowfall and cold temperatures in our area, we should still be prepared for the possibility of more seasonable weather.
In a feat unmatched by any other United States hospital, Northwestern Memorial Hospital is ranked first for survival of patients suffering heart failure and second for survival of patients with heart attack and stroke, the three most common and dire cardiovascular health threats.
World-renowned surgeon, scientist, and inventor Eric A. Rose, MD, was awarded the 2017 Earl Bakken Scientific Achievement Award by The Society of Thoracic Surgeons during the organization’s 53rd Annual Meeting.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded approximately $1.8 million from the National Institute of General Medical Sciences of the National Institutes of Health to develop a series of drug candidates for a number of diseases, including heart disease, rheumatoid arthritis and several neurodegenerative disorders.
Researchers at The University of Kansas Cancer Center have found that high doses of drugs commonly used to fight high cholesterol can destroy a rogue protein produced by a damaged gene that is associated with nearly half of all human cancers
Survival statistics, surgeon-specific experience, and complication rates are the types of information most wanted by parents of children with congenital heart disease, according to a survey released at the 53rd Annual Meeting of The Society of Thoracic Surgeons.
Elderly patients with aortic stenosis (AS) and medium surgical risk experienced better than expected results after undergoing traditional surgical aortic valve replacement (SAVR), according to research presented at the 53rd Annual Meeting of The Society of Thoracic Surgeons.
Cardiac monitoring remains a key element in caring for hospitalized patients who are critically ill, and it takes high levels of knowledge and skill to ensure accurate results from ECGs. As part of its ongoing efforts to standardize clinical practice and improve patient outcomes, AACN has updated its practice alerts related to dysrhythmia and ST-segment monitoring.
Cardiothoracic surgeon Richard L. Prager, MD, from the University of Michigan in Ann Arbor, was elected President of The Society of Thoracic Surgeons during the organization’s 53rd Annual Meeting in Houston.
Renowned quality improvement expert and public reporting advocate David M. Shahian, MD is the recipient of The Society of Thoracic Surgeons 2017 Distinguished Service Award, presented at the Society’s 53rd Annual Meeting.
Attendees of the STS 53rd Annual Meeting crowded into a packed session to hear about newly revealed research regarding a critical patient safety issue.
A tablet computer application helped heart patients with drug-eluting stents take their medications correctly, a study from the University of Illinois at Chicago has found. Researchers found that patients in the intervention group had a 10 percent higher medication possession ratio than patients in the control group.
Emergency body cooling does not improve survival or functional outcomes in children who experience in-hospital cardiac arrest any more than normal temperature control.
In this month’s release, find new embargoed research about: impact of minimum wage on teen birth rates; trends in parental leave rates over 22-year period; and food insecurity and cardiovascular-related health outcomes among American Indians.
Researchers at Binghamton University, State University of New York have devised a new way to protect personal electronic health records using a patient’s own heartbeat.
Researchers from Florida Atlantic University and Harvard Medical School address the possible but unproven link between statins and diabetes, as well as the implications of prescription of statins for clinicians and their patients. They emphasize that the risk of diabetes, even if real, pales in comparison to the benefits of statins in both the treatment and primary prevention of heart attacks and strokes. The editor-in-chief published the commentary and his editorial online ahead of print.
Using data from a national study, Johns Hopkins researchers determined that using heart CT scans can help personalize treatment in patients whose blood pressure falls in the gray zone of just above normal or mild high blood pressure.
A drug that's commonly used to treat high blood pressure is being repurposed for a rare tissue cancer in Europe. The medication, named propranolol, was recently granted Orphan Drug Designation by the European Commission (EC).
Investigators at the University of Utah have identified distinct differences in the hearts of advanced heart failure patients who have defied the odds and showed signs of recovery from the disease. Published online in the journal Circulation, the new findings could help clinicians identify the best candidates for cardiac recovery therapies.
Studies show that people who are chronically lonely have significantly more heart disease, are more prone to advanced cancers and strokes, and are more likely to develop neurodegenerative diseases such as Alzheimer’s.
The Council advises on matters relating to the cause, prevention, diagnosis and treatment of heart, blood vessel, lung and blood diseases; the use of blood and blood products and the management of blood resources; and on sleep disorders.
Researchers at the UCLA School of Nursing are addressing health challenges related to issues of the heart, the leading cause of death worldwide – from chronic health concerns faced by individuals born with congenital heart disease to those who are at risk or have developed cardiovascular disease.
Replacing biomass and kerosene cookstoves used throughout the developing world with clean-burning ethanol stoves may reduce hypertension and cardiovascular risk in pregnant women, according to new research published online, ahead of print in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
In a clinical trial in Nigeria that replaced biomass and kerosene cookstoves with clean-burning ethanol stoves, researchers were able to reduce by two-thirds the risk of high blood pressure and cardiovascular disease in pregnant women.
People who use cocaine regularly are at high risk of coronary artery disease. A study in the Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine (ASAM), reports that stopping or reducing cocaine use can potentially reverse the process of coronary atherosclerosis. The journal is published by Wolters Kluwer.
The Chronic Total Occlusion (CTO) Summit 2017 will feature the latest research and techniques available for interventional cardiologists in this emerging subspecialty of complex coronary artery disease. Now in its 14th year, the two-day course will take place February 23-24 at the New York Marriott Marquis.